LMG Life Sciences recognizes Hogan Lovells as Regulatory Firm of the Year for 2022

LMG Life Sciences recognizes Hogan Lovells as Regulatory Firm of the Year for 2022

Awards & rankings | 16 September 2022

Hogan Lovells is pleased to announce that it was named Regulatory Firm of the Year for the fourth time at the LMG Life Sciences annual awards event for 2022, with Janice Hogan named as the Regulatory Attorney of the Year in the FDA Medical Device category. The awards program, now in its 10th year, aims to highlight the best in practice in the industry following a thorough survey of the life sciences sector. Awardees are determined through a rigorous research process that aims to identify excellent legal service over a 12-month period.

Hogan Lovells has had a noteworthy year of advising major life sciences clients on a range of regulatory matters, including product development, FDA clearance, pricing and reimbursement, and post-approval compliance and enforcement. The firm was notably active for many emerging clients in post-pandemic matters, bringing innovative products to market and supporting across the full life cycle, especially when bridging the gap between health care and technology.

In addition to the final winners, Hogan Lovells was also shortlisted in the Life Cycle Firm of the Year – United States, FDA Litigation & Enforcement Firm of the Year, and Government Investigations Firm of the Year categories. Individually, four partners were shortlisted in Attorney of the Year categories, including Alice Valder Curran (Regulatory: Pricing & Reimbursement), Steve Abrams (Corporate), Cullen Taylor (Licensing & Collaboration), and Robert Underwood (Patent Strategy – Massachusetts).

View the full list of winners and more about the methodology here.